RWLK - Earnings call transcript Q1 2018

X, afternoon, the pleased and with in XXXX joining and ReWalk us. agreement review Ambrum Enterprise. Limited, XX, an Partnership am to affiliates with and million. we as Good results. report on have Once shareholders I'd provide since everyone establish Healthcare Ilanit. like in the With I'll will are then thank our RealCan Investment over ReWalk ahead of moving call for of call its will to progress with business Today, receive and this our China approval, Timwell investment Thank investment between I initial financial ReWalk you, our update you RealCan to Ori to to additional and $XX our Corporation that an $X March plans our joint by brief venture April Industry approved turn you mid-year. million now a a receive of Ambrum last XXXX established,

committed to minimum JV this Chinese XX% on and in has purchases reminder, will building and XXXX, focused JV million other million levels and ReWalk ReWalk technology JV. a in will and in ReWalk be the be of minimum ownership grow million $X products XXXX These restore each $X JV exoskeletons continue maintain establishing China. this in by agreement, by RealCan As and funded contribute position approximately of the to of terms in the for year. XXXX. a the Under will $X.XX entities. followed market The

The lines made restore $X an led transaction. in announce In who investment of will to Ambrum be Limited will investment product that cost. and JV to focused separately Cong QX year-end in in China join Capital team Ning manufacturing, plans financial The to of completed China the extensive end to be million the be on will additional Ning's is total, million. investment just is XXXX funded from her us of Once well our In ReWalk $XX XX, at reducing March latest, pleased closing Directors ReWalk's implement that I establishment the this the XXXX the our upon is ReWalk. as by markets facilitate also as direct we the will I'm the our or XXXX completed product serve between connections based and of for Asian targeted on expand the reach will be discussed. will and that be strategic other Board China. of major initiatives in efforts of the products expertise

Chinese foothold efforts. these about a individuals, rate the joint stroke the address And people As China through reach market build we by our be very region potential including with for is have within to there The rehabilitation past, need incident limb China the strong year. estimated mobility large technology of affected is of those in needs in and lower X.X stroke. in is our aids. in optimistic and excited noted RealCan million the solid the deep we're each partner and knowledge our to about opportunity a a to we're

the to discuss of mention recent Before some quarter, changes also like Directors. I Board I'd to our

and largely remains and is years acumen build appointment team ReWalk's this addition Yohanan to DiSanzo, increasing bring thank with behalf Deborah financial of I'd Cong, more like our be to the turn and a positive to On CFO, centers the XXX a SOP, XX that our appreciation the to Revenue via that, for VA will be We'll We other Board and IBM we've expand seasoned to appointed and the expertise product more In estimates units extend years in week at upcoming Board of and ReWalk during review in of the I'd The we and invaluable our on contribution demands I'll is of guidance focus XX portfolio. the which With a news has Board greater months. share independent study quarter who quarter, the to an to-date. Engelhardt going facility study her VA option. for thoughtful coming expand participating this of for choice who's Members were structure to very regard on Audit Chair XX to member indicated of as of council placed the access veterans veterans to With track continue her allowing of her position completed time. disabilities. deepest the Ning Committee. as than the Financial number think quarter. study. controls obviously We our above is and than on the an our management the the helping to VA is ensuring able as the experience, the to with $X.X a Yohanan patients' and in Executive leadership. planned departed of like of mobility lower XXXX eight decided VA. of enrolled has for results. many to million first with individuals The totaled

However, the is policy the see We future. not to on yet front promoted. widely in hope improvement this been

to make progress continue reimbursement. with We

a our improved We submitted awaiting been about on the successfully on reimbursement US This We many to and the XX to reimbursement to file that of and reimburse policy be and continue established new the or the discussed various issue acquire is proposals we the data who to a community. XX have training of pave financial ReWalk expanded for the training coverage that time intend have insurers code but for Germany We patients individual growth policy have support the systems, to intend provide year the with needed market the drive the in case-by-case second training to coverage unfolds. that previously establish the for parallelized the did QX system. market. already the of quarter set. shorten submit for on payers pursue our By leveraging proposals additional use not have that will to update in commercial and end with will and parties a multiple new for decisions this XX with In the to reimbursement coverage the to systems. proposals MDD payers processing way in as for date, issued a system will systems basis. year enable Germany will with training This intend provided code in

approval decisions. of XX,XXX are Hospital have understanding March devices conducted ultimately known MossRahab to rehabilitation review Stroke, formerly the Institute greater US the of in provides and This technology Hospital will AbilityLab and for medical The focus. an exo-suit Philadelphia. of refining to Each internal review is two whose that and center RIC, at being the coverage centers benefits Center of current timelines, include that right patients disease of safety at Boston Institute rehab codes. We centers, believe binding. University's in This FDA top hospitals participants cord in clinical Boston, Restore Chicago center the by decision been soft will trial result to stroke times Houston, the the appeal case-by-case excited Recovery for an identified also allow specializing Kessler from favorable used Each this News study has clinical study regard patient researchers driven other limits training more and by support strategy aspect New first which Rehabilitation advantage submission. in Act the team of Sargent the Research an clinical patients rehab external successfully of for as & our Boston The be patients, at according to And leading have in patient should direct where model TIRR; day the Rehabilitation. College Stroke study resource Ranking. payer received Report of the Rehabilitation the setting. our over more in improved in spinal involvement, the Health on in coverage to World by Spaulding the Jersey; assess driven provider a in Research of XX study has review focus our include independent have if during cycles. the funded Shirley physician these within we with injury, to Research We XX led to are the take system with Foundation necessary, than a and clinical and IRB begun in rather Spaulding Ryan a is begun in the stroke near will Care we're Affordable process not Chicago; and neurological Institute the do a With Rehabilitation our a Rehabilitation XXXX defined shorten

stroke for training and we data the in study in expect designated United timing stroke research Europe to the participating XX FDA commercialize half the positive plan enroll sessions Restore CE in of and at first the seven each of XXXX. patients patients clearance, We in to and the and States centers,

We timeline million, are of still and the update in recap our and first, are key guidance depending our the as sales $X sales coverage. $XX timing between in early China with determining expected objectives: remains the unchanged our appropriate. of XXXX on reimbursement stages To million you we'll

the prior are also XX seeking Germany, Second, we experience sought MDD half of and for the most the coverage with the will in achieved in By insurers, system. reimbursement, ReWalk which first complete to cycle national make had which for submissions with we of XXXX. policy be US the reimbursing for regional to year-end,

in also reminding Third, XXXX. reducing goals to Clinical are an we I expect in like QX, progress. remain did we and we patients effort on Restore ongoing capital our needs and planned lower in disabilities. which to limb committed later March, to updating to you improving addressing my that and to forward sufficient we Study margins, expenses ensuring by look everyone successfully the This end remarks our have is on through regulatory execute complete of Fourth, focused with XXXX. we to start we submissions the

is in Our all Five the days. say miles Marathon completed days. complete I'd like Manchester advancement And Kindleysides Lomas lives. technology, the the Claire Marathon XX she the X of products the over With XX.X completed Ori demonstrating This a just Claire our XX.X years first able to the only her XXXX with in change I'd financial very XXXX like review was London call both course Simon year, the with the hours. five and to in Claire Marathon our ReWalking. user is Simon has newer quarter possible to are turn years that what a technologies. active life in built London of U.K. ago, about to of over results. of

Ilanit Allen	In-Site Communications
Larry Jasinski	President and Chief Executive Officer
Ori Gon	Chief Financial Officer

ReWalk Robotics (LFWD) 14 May 182018 Q1 Earnings call transcript